gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
EBV-specific TCR on the engineered T cells recognizes EBV peptide–HLA-A*11:01 on target cells and triggers CTL killing via perforin/granzyme release and Fas–FasL-mediated apoptosis.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
peptide–MHC class I (pMHC) complex
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06135922
disease_id_num_tar_ref
5291
drug_id_num_tar_ref
14395